IVR — Investigator Resources Income Statement
0.000.00%
Last trade - 00:00
- AU$75.45m
- AU$69.99m
- AU$0.13m
- 39
- 22
- 47
- 30
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.044 | 0.122 | 0.049 | 0.275 | 0.128 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.94 | 14.2 | 2.1 | 4.41 | 2.77 |
Operating Profit | -2.89 | -14.1 | -2.05 | -4.13 | -2.64 |
Gain / Loss on Sale of Assets | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.87 | -14 | -1.98 | -4.13 | -2.64 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.87 | -14 | -1.98 | -4.13 | -2.64 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.87 | -14 | -1.98 | -4.13 | -2.64 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.87 | -14 | -1.98 | -4.13 | -2.64 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.004 | -0.017 | -0.002 | -0.003 | -0.002 |